Stay up to date with all the latest conference news, product launches and press releases from PredictImmune and its pioneering tools for the guidance of treatment options in immune-mediated diseases.
PredictImmune announces new patent grants and allowances across the UK, EU and Canada Patents cover PredictImmune’s first family of intellectual property relating to methods for predicting autoimmune disease risk Cambridge, UK, 18 October 2018: PredictImmune,...read more
PredictImmune founders, Professor Ken Smith and Dr Eoin McKinney to present at Immunology of Diabetes Society Congress 2018. Cambridge, UK, 16th October 2018: The end of October sees the return of the Immunology of Diabetes Society for their 16th congress, and...read more
PredictImmune’s CSO, Dr Eoin McKinney and University of Cambridge colleague, Dr James Lee, presenting at the UEG Week Course in Vienna.
PredictImmune’s CSO, Dr Eoin McKinney and University of Cambridge colleague, Dr James Lee, presenting at the UEG Week Course in Vienna. Cambridge, UK, 8th October 2018: October offers a great opportunity to hear more about the impact of prognostication on...read more
PredictImmune invited to present at the Crohn’s & Colitis Foundation IBD Biomarkers Summit, October 17-18, Newark, NJ, USA
PredictImmune invited to present at the Crohn’s & Colitis Foundation IBD Biomarkers Summit, October 17-18, Newark, NJ, USA PredictImmune CSO, Eoin McKinney to lead discussion on fluid biomarkers Cambridge, UK, 03 October 2018: PredictImmune, developers of...read more
PredictImmune: Announced as Finalist in the Cambridge Independent Science & Technology Awards Cambridge, UK, 14th September 2018: PredictImmune is pleased to be selected as one of the finalists, in the “start up of the year” category of the Cambridge...read more
PredictImmune’s Prognostic Biomarker Test for IBD to feature in Platform Presentations at Upcoming Conferences
PredictImmune’s Prognostic Biomarker Test for IBD to feature in Platform Presentations at Upcoming Conferences Cambridge, UK, 17th September 2018: PredictImmune’s first product, a prognostic biomarker test for IBD will be the subject of two key presentations at...read more
PredictImmune Appoints New CEO Paul Kinnon appointed to drive the company’s next phase of development - commercialisation and expansion Cambridge, UK, 02 July 2018: PredictImmune, a developer of pioneering prognostic products for guiding treatment...read more
PredictImmune join the Babraham Research Campus community Developer of pioneering tools for guiding treatment options in immune-mediated inflammatory diseases choose Babraham Research Campus as permanent base within the Cambridge Cluster Babraham, 14th May 2018: The...read more
PredictImmune to exhibit at the British Society of Gastroenterology Annual Meeting in Liverpool, June 5-6
PredictImmune to exhibit at the British Society of Gastroenterology Annual Meeting in Liverpool, June 5-6 Developer of prognostic tools to guide treatment of patients with immune-mediated diseases will be available at stand A176 Cambridge, UK 31 May 2018:...read more
Get in Touch
If you have an enquiry, contact PredictImmune using the following contact details. Alternatively, submit the enquiry form and one of our team will be in touch as soon as possible to see how we can meet your needs.
T +44(0)1223 804 195
PredictImmune develops pioneering tools for guiding treatment options in immune mediated diseases such as Inflammatory Bowel Disease.